Ubiquinone CoQ10

View my plan →

The short answer

The oxidized, widely studied CoQ10 form; it raises CoQ10 levels and is used in condition-specific trials.

Evidence and scope: Conditional or population-specific
This status does not grade the ingredient for every goal, outcome, or person.
Important limitation: Benefit depends on the population, formulation, baseline status, and objective; results should not be generalized.
Before deciding: Key concern: Warfarin, blood-pressure medicines, chemotherapy, and heart-failure treatment require coordination.

01 / PRACTICAL GUIDE

Dose, absorption, and combinations

These are indication-specific reference or studied ranges—not a personalized prescription. Start with the objective, then check the form, label, medicines, and health conditions.

Reference range by objective

Meeting usual needs100–300 mg/day with fat in many trials

Reference or studied range—not a personalized prescription. The product label or a clinician may specify a different dose.

Dose source ↗

More is not automatically better. A clinician or product label may specify a different amount.

Absorption / solubilityFat-soluble / lipid-based

Fat-soluble or lipid-based. Absorption generally improves with a meal containing fat.

How it is commonly taken

Take with a fat-containing meal; split larger doses.

Do not combine casually

Warfarin, blood-pressure medicines, chemotherapy, and heart-failure treatment require coordination.

Dose and use source ↗

Dose and use links lead to primary or official source material. Search links are discovery tools, not proof that every returned paper applies.

02 / EVIDENCE

What the research says

We keep supportive, mixed, negative, safety, and contextual findings together. The headline never replaces the underlying papers.

1research papers in this ledger

11unique primary studies represented

1,573unique participants represented

These are audited counts for this JIVANA collection, not search-result totals. Participants are counted once when multiple papers use the same cohort; review papers are not added again to participant totals.

Open the research timelineResearch timeline

Entries are ordered by publication year. A study period appears only when the source reports it.

2021

Mixed or qualifiedPMID 35608922 · CD008684

Coenzyme Q10 for heart failure

Moderate-certainty evidence suggested lower all-cause mortality and heart-failure hospitalization, driven largely by one or two trials. Every study had high or unclear risk of bias, and evidence for ejection fraction, exercise capacity, myocardial infarction, stroke, and adverse events was low, very low, or inconclusive; this is adjunctive heart-failure care, not self-treatment.

Published: 2021n=1,573 participants11 primary studies represented

Study design and methods

Design: Cochrane systematic review of 11 randomized trials
Population: 1,573 adults with heart failure
Intervention: Coenzyme Q10, generally ubiquinone formulations, plus standard care versus placebo or conventional care
Outcome: Mortality, heart-failure hospitalization, cardiac events, ejection fraction, exercise capacity, and adverse events

Open research record ↗

Unscreened discovery appendix—not evidence581 candidate publicationsSearch run: Aug 21, 2026

Complete for the displayed PubMed query at the search timestamp—not for all databases or every possible synonym. Candidates can be irrelevant, duplicate the same study, or report negative findings. They are never summed as evidence or participants until screened.

03 / SOURCES

Start with the source material

Official evidence overviewPubMed bounded human-evidence search Live PubMed discovery searchNational Library of Medicine

The live search is for discovery only. Search-result counts change and are not included in the audited totals above.

Recent PubMed discovery recordsDirect links to the first 12 records returned by the reproducible search. These are discovery candidates—not reviewed summaries or a count of supportive findings.

04 / EXPERT CONTEXT

Expert context—not evidence

Expert positions are dated context—not scientific evidence. They never raise the evidence status or become consensus by repetition.

No direct, source-verified endorsement is currently recorded. Research authorship or discussion alone is not treated as endorsement.